These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4842666)

  • 1. Renal dysfunction after treatment with isophosphamide (NSC-109724).
    DeFronzo RA; Abeloff M; Braine H; Humphrey RL; Davis PJ
    Cancer Chemother Rep; 1974; 58(3):375-82. PubMed ID: 4842666
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of isophosphamide.
    Creaven PJ; Allen LM; Alford DA; Cohen MH
    Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial of isophosphamide (NSC-109724)--results and side effects.
    Bremner DN; McCormick JS; Thomson JW
    Cancer Chemother Rep; 1974; 58(6):889-93. PubMed ID: 4614898
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
    Ahmann DL; Bisel HF; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):861-5. PubMed ID: 4615785
    [No Abstract]   [Full Text] [Related]  

  • 5. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
    J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with single high dosage iphosphamide therapy in metastasizing malignant neoplasms].
    Drings P; Fritsch H
    Verh Dtsch Ges Inn Med; 1972; 78():166-9. PubMed ID: 4353153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of ifosfamide in the treatment of malignant neoplasms].
    Czownicki Z; Utracka B; Till A; Styrna M
    Nowotwory; 1973; 23(3):285-90. PubMed ID: 4757587
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.
    O'Connell TX; Berenbaum MC
    Cancer Res; 1974 Jul; 34(7):1586-91. PubMed ID: 4833912
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective inhibition of human distal tubular function by demeclocycline.
    Wilson DM; Perry HO; Sams WM; Dousa TP
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):737-40. PubMed ID: 4356065
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of renal function in the differential diagnosis of kidney disease.
    Brod J
    Br Med J; 1971 Jul; 3(5767):135-43. PubMed ID: 5557861
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of myxedema on the renal diluting and concentrating mechanism.
    Discala VA; Kinney MJ
    Am J Med; 1971 Mar; 50(3):325-35. PubMed ID: 5573150
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical examination of renal function.
    Garfinkel HB; Lifschitz MD
    Tex Med; 1974 Apr; 70(4):55-61. PubMed ID: 4821681
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural-functional correlations in renal disease. II. The correlations.
    Schainuck LI; Striker GE; Cutler RE; Benditt EP
    Hum Pathol; 1970 Dec; 1(4):631-41. PubMed ID: 5521736
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal dysfunction associated with methoxyflurane anesthesia. A randomized, prospective clinical evaluation.
    Mazze RI; Shue GL; Jackson SH
    JAMA; 1971 Apr; 216(2):278-88. PubMed ID: 5107910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasopressin-resistant hyposthenuria in advanced chronic renal disease.
    Tannen RL; Regal EM; Dunn MJ; Schrier RW
    N Engl J Med; 1969 May; 280(21):1135-41. PubMed ID: 5782121
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal function tests in experimental toxicity studies.
    Diézi J; Biollaz J
    Pharmacol Ther B; 1979; 5(1-3):135-45. PubMed ID: 40261
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotype standardization for drug-induced kidney disease.
    Mehta RL; Awdishu L; Davenport A; Murray PT; Macedo E; Cerda J; Chakaravarthi R; Holden AL; Goldstein SL
    Kidney Int; 2015 Aug; 88(2):226-34. PubMed ID: 25853333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of renal function--glomerular and tubular.
    Duarte CG; Preuss HG
    Clin Lab Med; 1993 Mar; 13(1):33-52. PubMed ID: 8462268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.